Diagnosing lung diseases is easier than it used to be with a new state-of-the-art pulmonary function machine recently installed at St. Luke's Hospital. A Vmax Series product from Sensor Medics is a ...

Good breathing is at the heart of good health. When asthma or shortness of breath appears, a person might be sent for pulmonary function tests. Arlene Dunlap of Piscataway, N.J. knows those tests well ...

Researchers have shown that antibiotic concentrations can be detected and measured in the exhaled breath of patients receiving intravenous treatment, raising the possibility that a simple breath test ...

A new study led by researchers at Johns Hopkins Kimmel Cancer Center is showing a novel blood test can detect the presence of lung cancer with over 90 percent accuracy. The test uses artificial ...

CLEVELAND — November is Lung Cancer Awareness month. The disease is the leading cause of cancer death around the world, and according to the American Lung Association, nearly a quarter of a million ...

A retrospective pooled analysis of 1,100 patients demonstrates the Nodify CDT® test’s consistent clinical performance across nodule sizes and patient populations ...

A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a ...

A pulmonologist discusses the history and influence of race-based reference equations in pulmonary function testing interpretation and patient care.

Affinity Technologies, Inc. (NASDAQ:BIAF) released its financial results for the year ended December 31, 2025, according to a statement issued Friday. The biotechnology company reported revenue of $6.

CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings.

According to the American Lung Association, the national five-year lung cancer survival rate is about 29.7 percent. The ...